Sponsor & Exhibitor Profiles
Gedeon Richter Plc
Headquartered in Hungary, Gedeon Richter Plc. is an innovation-driven specialty pharmaceutical company. Innovation and the research of original drug molecules have been key elements in the Company’s strategy since its foundation in 1901. Several years ago, Gedeon Richter identified the growing importance of biological drugs over the medium to long-term and took the strategic decision to enter this novel area of medicine in 2006. When selecting candidate products Richter proceeded very carefully, focusing on certain therapeutic areas, notably rheumatology, immunology and osteoporosis. Our goal is to provide cutting-edge approaches that address the unique needs of patients, contributing to a healthier and more fulfilling life.
Inozyme Pharma, inc.
Inozyme Pharma is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases driven by pathologic mineralization and intimal proliferation which impact the vasculature, soft tissue and skeleton. We are initially focused on developing an enzyme therapy to treat ENPP1 and ABCC6 Deficiencies, two rare genetic diseases associated with significant morbidity, mortality, and unmet medical need.
Kyowa Kirin International Plc.
Kyowa Kirin strives to create and deliver novel medicines with life-changing value. As a Japan-based Specialty Pharmaceutical Company with a heritage of 70+ years, we apply cutting-edge science including an expertise in antibody research and engineering, to address the needs of patients and society across multiple therapeutic areas including Nephrology, Oncology, Immunology/Allergy and Neurology. Across our four regions – Japan, Asia Pacific, North America and EMEA/International – we focus on our purpose, to make people smile, and are united by our shared values of commitment to life, teamwork/Wa, innovation, and integrity.
You can learn more about the business of Kyowa Kirin at: https://international.kyowa-kirin.com/uk/
UCB Biopharma SRL
At UCB, we believe everyone deserves to live the best life that they can – as free as possible from the challenges of disease. We develop solutions across neurology, immunology, and other areas where our expertise, innovation, and ambition align with the needs of those who live with severe diseases.
We are curious and collaborative, driven to create valuable solutions and improve the health and wellbeing of our people, our communities and the planet. We seek out tools, technologies, and partners that help us respond to patient needs with purposeful innovations that make a truly meaningful impact.